Brian Burkavage - 20 Mar 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Accounting Officer
Signature
/s/ Brian Burkavage
Issuer symbol
IOBT
Transactions as of
20 Mar 2023
Transactions value $
$0
Form type
4
Filing time
22 Mar 2023, 16:21:02 UTC
Previous filing
02 Jun 2022
Next filing
24 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +50K $0.00 50K 20 Mar 2023 Common Stock 50K $1.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of these options vest on March 20, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.